Objectives. Patients with SLE are at risk for premature atherosclerosis and metabolic syndrome. Cytokines produced by adipocytes, adipokines, are important in glucose/lipid metabolism and the development of atherosclerosis. The objectives of this study were to evaluate leptin, adiponectin and ghrelin concentrations in paediatric SLE (pSLE) and to correlate these concentrations with measures of disease activity, serum lipid concentrations, measures of insulin resistance and serum homocysteine concentrations. Methods. Two hundred and eight samples from 105 patients with pSLE and 77 samples from 77 healthy paediatric controls were evaluated by ELISA to measure leptin, adiopnectin and ghrelin. Students' t-test was used for analysis. Concentrations of adipokines were correlated with disease activity, serum lipids, insulin resistance and homocysteine. Results. Overall 35 SLE patients (34%) had an abnormally elevated leptin level. The only significant correlation of leptin concentrations was with homocysteine concentrations but not disease activity, prednisone dose, lipids or insulin resistance. There was no difference in the mean adiponectin concentrations between the control and patient groups and none of the patient samples were below the normal lower limit while seven were elevated. There was a significant correlation of adiponectin concentrations with prednisone dose, lipid concentrations and insulin resistance but not with disease activity or homocysteine. Elevated ghrelin concentrations were found in 20% of the pSLE patients. The only correlation of ghrelin concentrations was with homocysteine. Conclusions. Adipokines are novel biomarkers in pSLE. They may represent cardiovascular risk and are not just surrogate markers for disease activity, therapy or serum lipids. Their correlation with atherosclerosis needs to be explored.
Introduction
SLE is a chronic autoimmune disease characterized by the production of autoantibodies and chronic inflammation. It has been recognized since the early 1970s that patients with SLE are at risk for premature atherosclerosis [1] . It has been postulated that the chronic inflammation of SLE, the production of autoantibodies and the presence of metabolic syndrome (characterized by elevated blood pressure, central obesity, dyslipidaemia and glucose intolerance) are important in the development of premature atherosclerosis in SLE [2] . Adipose tissue secretes a variety of cytokines with autocrine/paracrine and endocrine functions that influence body weight and glucose/lipid metabolism. These cytokines which include leptin, adiponectin, IL-6, TNF-and resistin, are collectively known as adipocytokines or adipokines. Leptin and adiponectin are the two major insulin-sensitizing adipokines secreted from adipose tissue.
Adiponectin acts mainly on skeletal muscle and liver, and increases insulin sensitization. It has been suggested that adiponectin may have an important protective role in the development of atherosclerosis as adiponectin inhibits the production of proinflammatory cytokines and can render macrophages resistant to pro-inflammatory stimuli [3] [4] [5] [6] [7] . Leptin, a second important adipokine, is important in energy balance. Serum concentrations of leptin have been positively correlated to adipose tissue mass with higher concentrations in women than in men. Adult patients with SLE have been shown to have elevated serum leptin concentrations [8] [9] [10] . A third cytokine, ghrelin, which is secreted mainly from the stomach, acts as an appetite-stimulating hormone and plays a role in regulation of insulin secretion. Ghrelin has been shown to have beneficial cardiovascular actions by decreasing vascular calcification and inhibiting endothelial cell cytokine production [11, 12] .
The primary aim of this study was to evaluate leptin, adiponectin and ghrelin concentrations in a large cohort of paediatric patients with SLE. Additional aims were to correlate these concentrations with measures of disease activity, treatment, serum lipid concentrations, measures of insulin resistance and serum homocysteine concentrations.
Materials and methods

Subjects and samples
Following informed consent 208 fasting serum samples were collected from 105 patients with paediatric SLE (pSLE). The cohort consisted of 21 males (20%) and 84 females (80%) with a mean age of 14.98 AE 2.46 years who attended the Lupus Clinic at SickKids Hospital, Toronto and were enrolled in a prospective study of examining non-invasive measurements of atherosclerosis (Table 1 ). All children fulfilled at least 4/11 of the ACR criteria for the diagnosis of SLE and were between the ages of 10 and 18 years at the time of the study [13] . This work was approved by the Research Ethics Board of SickKids Hospital.
Serum samples were collected from 127 otherwise healthy children (50 males and 77 females) with mean age of 10.04 AE 3.48 years (range 3-18 years). It has been recognized that leptin and adiponectin concentrations may vary with age and we found that this was true up to the age of 9 years in our healthy controls. As >95% of patient samples were from patients 59 years of age, we used 9 years as the cut-off for both patients and the control group. This left 77 individuals (21 males and 56 females) in the control group. Peripheral venous blood samples were collected between 1999 and 2006. The blood samples were centrifuged for 12 min at 800 g; plasma was extracted and stored at À808C until testing which may have been up to 7 years. None of the samples had been previously thawed prior to testing. The samples were tested for ghrelin, leptin and adiponectin to establish a normal range. The healthy serum control samples were obtained from children seen in the Rheumatology Clinic at SickKids Hospital and were found not to have a rheumatological or any other acute or chronic illness.
ELISA
Leptin. A direct sandwich assay was used to measure leptin according to instructions outlined by the manufacturer with patient serum or control serum diluted 1 : 4 (ELISA Kit, Linco Research, MO, USA). The absorbance was measured by 450 nm with an ELISA plate reader (Versamax ROM v3.13; Molecular Devices, Sunnyvalle, CA, USA). The concentration was determined using computer program SoftMax Pro 4.3 (SoftMax, San Diego, CA, USA). The assay had a sensitivity of 0.50 ng/ml.
Adiponectin. Direct sandwich ELISA assay for adiponectin was performed according to the method outlined by the manufacturer (ELISA Kit, Linco Research). However, when measuring adiponectin serum samples were pre-diluted 1 : 500 prior to adding to the ELISA plate. The absorbance was measured at 450 nm with an ELISA plate reader (Versamax ROM v3.13). The concentration was determined using computer program SoftMax Pro 4.3. The assay had a sensitivity of 0.78 ng/ml.
Ghrelin. Direct sandwich ELISA assay for unacylated ghrelin was performed according to the method outlined by the manufacturer with serum samples diluted 1 : 2 (ALPCO Diagnostics, Salem, NH, USA). The absorbance was measured at 405 nm with an ELISA plate reader (Versamax ROM v3.13). The concentration was determined using computer program SoftMax Pro 4.3. The assay had a sensitivity of 0.6 pg/ml.
Statistics
The data are reported as means AE S.D. A two-tailed Student's t-test was used to compare control and study groups. When indicated, z-score transformation was performed prior to analysis. A P-value of <0.05 was considered as statistically significant. Statistical analyses were performed using standard computer software (Microsoft Excel Statistical Addin, Microsoft Corporation, Seattle, Washington, USA).
Results
Leptin
As expected, we found a significant correlation of leptin concentrations and height, weight and BMI in controls (data not shown). All data for pSLE patients are reported for the initial sample only unless otherwise indicated as serial measurements. This is true for adiponectin, ghrelin as well as for leptin concentrations.
When compared with controls, mean serum leptin concentrations were elevated in the SLE cohort (22.4 AE 18.2) as well as for female patients (24.3 AE 19.2 vs 10.2 AE 7.7; P < 0.0001) with a trend for elevated concentrations in males (14.6 AE 13.2 vs 8.6 AE 11.0; P ¼ 0.08) ( Table 2 ). Overall 35 patients (34%) had an abnormally elevated leptin concentration (33.3% of males and 33.7% of females). We did not find a statistically significant difference in the serial leptin concentrations when we compared the initial sample to a sample repeated 6-24 months later (103 samples from 85 patients) (data not shown). Unlike the results seen in controls, we did not find a statistically significant correlation of leptin concentrations with height for both sexes while there was a statistically significant correlation with weight for female (r ¼ 0.640; P < 10 À8 ) but not male patients. There was a significant correlation with BMI only (r ¼ 0.762; P < 10 À13 for females and r ¼ 0.725; P ¼ 0.001 for males). When we attempted to correlate leptin concentrations with active SLE, we did not find any significant correlation of leptin concentrations with ECLAM or SLEDAI scores (data not shown). The mean SLEDAI score was 3.51 AE 3.54 (range 0-16) and mean ECLAM score was 2.25 AE 2.06. None of the patient samples were below the normal lower limit while seven adiponectin measurements from seven patients were elevated ( Table 2) . None of the controls had elevated adiponectin concentrations. We did not find a statistically significant difference in adiponectin concentrations when we compared the initial sample to a sample repeated 6-24 months later in the patients who had repeated samples (103 samples from 85 patients) (data not shown). There was no correlation of adiponectin concentrations with height, or BMI for both sexes although there was a negative correlation of adiponectin concentrations with weight in male (r ¼ À0.56; P ¼ 0.013) but not female patients. There was no correlation of adiponectin concentrations and ECLAM or SLEDAI scores.
Ghrelin
When compared with controls, the mean ghrelin concentrations for the total SLE group as well as for both male and female patients were not significantly elevated ( Table 2 ). Elevated ghrelin concentrations were found in 20/99 patients (20%) (19% of the males and 20% of the females). We did not find a statistically significant difference in ghrelin concentrations when we compared the initial sample to a sample repeated 6-24 months later in the patients who had repeated samples (103 samples from 85 patients) (data not shown). There was no statistically significant correlation of ghrelin concentrations with height, weight, BMI, SLEDAI or ECLAM concentrations (data not shown).
Associations with prednisone dose
There was a statistically significant correlation of adiponectin concentrations and prednisone dose in both males (r ¼ 0.655; P ¼ 0.0017) and females (r ¼ 0.413; P ¼ 0.0001) but there was no correlation of prednisone dose with leptin or ghrelin concentrations (data not shown).
Correlation with lipid concentrations
We next correlated adiponectin, leptin and ghrelin with serum lipid concentrations ( Table 3) . The only significant correlations we found were a correlation of adiponectin concentrations in pSLE patients with total cholesterol for both males (r ¼ 0.296; P ¼ 0.01) and females (r ¼ 0.554; P ¼ 0.008); with high-density lipoprotein (HDL) in females (r ¼ 0.700; P ¼ 0.0009) but not males (P ¼ 0.32); with low-density lipoprotein (LDL) in males (r ¼ À0.288; P ¼ 0.01) but not in females (P ¼ 0.22); and with lipoprotein A for males (r ¼ 0.862; P < 0.001) but not for females (P ¼ 0.18). There was no correlation of adiponectin concentration with apolipoprotein (Apo) A1 or ApoB in males or females. We did not find any significant correlation of ghrelin or leptin concentration with any of the lipids measured.
Correlation with homocysteine concentrations
There was a statistically significant negative correlation of homocysteine concentrations with ghrelin in males (r ¼ À0.772; P ¼ 0.04) and a significant positive correlation with leptin concentrations in males (r ¼ 0.788; P ¼ 0.04). There were no correlations of homocysteine concentrations with ghrelin or leptin concentrations in females (P ¼ 0.278 and P ¼ 0.137, respectively) or with adiponectin concentrations for males (P ¼ 0.51) or females (P ¼ 0.22).
Correlation with measures of insulin resistance
There was no significant correlation of leptin or ghrelin concentrations with measures of insulin resistance (insulin concentrations, insulin C-peptide or haemoglobin A 1 C concentrations). However, there was a statistically significant correlation of adiponectin concentrations with insulin C-peptide concentrations (r ¼ 0.938; P ¼ 0.002) for males with a trend for a significant association with insulin concentrations (P ¼ 0.06). In contrast, there was no statistically significant association of either insulin C-peptide or insulin concentrations with adiponectin concentrations in females (P ¼ 0.64 and P ¼ 0.99, respectively).
Discussion
The development of atherosclerosis in patients with SLE is the result of a complex interaction of traditional risk factors, chronic inflammation, the production of autoantibodies and therapies used to treat the disease. Recent evidence has suggested that the adipokines leptin and adiponectin and the appetite-stimulating hormone ghrelin may be important in the development of atherosclerosis in otherwise healthy individuals and in disease states. In this study, we examined how these cytokines/adipokines interact with each other and the association with these adipokines and serum lipids, insulin resistance, homocysteine concentrations and measures of disease activity in a large cohort of patients with pSLE. Adiponectin has been shown to be important in the regulation of insulin sensitivity, energy homeostasis and more recently in the development of atherosclerosis. It has been reported that low serum adiponectin concentrations may be a risk factor for atherosclerosis in patients with metabolic syndrome and renal disease [14, 15] . In patients with type 1 diabetes mellitus, it has been suggested that adiponectin concentrations are increased in an attempt to decrease endothelial and vascular damage [16] . In our study, similar to what has been reported in type 1 diabetes mellitus, we found that some SLE patients had elevated adiponectin concentrations. Similar to a previous observation in adults with SLE, we did not find decreased adiponectin concentrations in any of our patients with pSLE [17] . Adiponectin concentrations were positively associated with multiple lipid concentrations: total cholesterol (both sexes), HDL (females only), lipoprotein A (males only) and negatively associated with LDL (males only). These results are consistent with previous studies in healthy individuals which found a positive association of serum adiponectin concentrations with HDL demonstrating that high adiponectin concentrations are associated with a low-risk lipid profile [3, 4, 14, [18] [19] [20] [21] . However, we did not find a correlation with triglyceride concentrations, or with ApoA1 and ApoB concentrations as previously reported in healthy individuals, suggesting that in patients with SLE the association of adiponectin with serum lipids is more complex than that found in the general population. Of importance, there was an association of adiponectin with insulin C-peptide and a trend for an association with insulin concentrations suggesting that in patients with SLE adiponectin concentrations are not decreased in the presence of insulin resistance as found in the general population. Of importance, adiponectin concentrations were significantly associated with prednisone in both male and female patients but not with disease activity. We suggest that this may be a biomarker for the metabolic syndrome phenotype seen in SLE patients. Our findings of high serum leptin concentrations in one-third of the patients with pSLE are in agreement with previous studies in adults with SLE [8] [9] [10] . This is in contrast with studies in juvenile idiopathic arthritis and adult RA which have shown either normal or low concentrations [8] [9] [10] [22] [23] [24] [25] . Similar to previous studies in healthy individuals, we found that leptin concentrations correlated with height, weight and BMI in controls. In contrast, in SLE patients, we found that leptin concentrations correlated with only BMI in both sexes. These results suggest that in patients with SLE other factors in addition to height, weight and BMI control leptin concentrations. Similar to previous studies in adults with SLE, we did not find an association with global measures of disease activity suggesting that leptin concentrations reflect a different process than disease activity [8] [9] [10] . We did not find an association of leptin concentrations with any of the lipids measured including triglyceride or HDL concentrations, although in healthy adults and children, leptin concentrations have been correlated with serum lipid measurements [26, 27] . Although dexamethasone has been shown to induce hyperleptinaemia, we did not find an association of leptin concentrations with prednisone dose at the time of leptin measurement or with mean prednisone dose in the 3 months prior to leptin measurement. Therefore, the hyperleptinaemia seen in SLE is likely not secondary to prednisone therapy. This lack of association of leptin concentrations and prednisone dose has been previously reported in adults with SLE [8, 9] . Lastly, we have found for the first time an association of leptin concentrations with homocysteine concentrations. Future studies are required to determine the control of leptin secretion in SLE.
Ghrelin has recently been shown to have an inhibitory effect on the production of pro-inflammatory cytokines [28] [29] [30] . The ghrelin concentrations were inversely correlated to leptin concentrations, a finding previously reported in healthy adults and seen in our healthy paediatric controls [31, 32] . Despite this inverse correlation with leptin concentrations, we did not find significant difference between ghrelin concentrations in pSLE patients and controls and there was no association of ghrelin concentrations with height, weight or BMI. These results confirm the findings in healthy individuals that these two cytokines function independently of each other. We did not find the previously demonstrated association of ghrelin concentrations with HDL concentrations [28] . However, similar to what we found with leptin, we did find a significant association of ghrelin concentrations with homocysteine although, as may be expected, the association of ghrelin concentrations with homocysteine concentrations was negative. There was no association of ghrelin concentrations with prednisone treatment. Our study suggests that measuring ghrelin does not add additional information to measuring leptin concentrations in SLE.
In this study, we have shown that leptin, adiponectin and, to a lesser extent ghrelin, cytokines which are important in energy homeostasis, may be important biomarkers in SLE. We suggest that adiponectin may be an important counter-regulatory molecule in SLE which is secreted in response to chronic inflammation or prednisone therapy to down-regulate the negative effects of pro-inflammatory cytokines, and therefore elevated concentrations may be protective. In contrast, elevated leptin concentrations may be an additional biomarker of the risk of metabolic syndrome or atherosclerosis. However, a limitation of our study was our inability to measure long-term cardiovascular outcome or all cardiovascular risk factors in our cohort, and therefore additional studies are required to not only confirm our results but to test the correlation of these biomarkers with markers of subclinical atherosclerosis.
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